Statistics
Publications
18
Citations
2.4K
H-Index
14
Active since
1982
Thomas Elebring is an author at AstraZeneca (Sweden) specializing in pharmacology, medicinal chemistry, and medicine.
Publications per year
1982–2012
18
18
The orphan receptor GPR55 is a novel cannabinoid receptor
Erik Ryberg, Niklas Larsson, S. Sjögren et al. · British Journal of Pharmacology · 2007 · 1.6K citations · Full text
Asymmetric synthesis of esomeprazole
Hanna K. Cotton, Thomas Elebring, Magnus Larsson et al. · Tetrahedron Asymmetry · 2000 · 252 citations
Identification and characterisation of a novel splice variant of the human CB1 receptor
Erik Ryberg, Huy Khang Vu, Niklas Larsson et al. · FEBS Letters · 2004 · 146 citations · Full text
Göran Engberg, Thomas Elebring, Hans Nissbrandt · Journal of Pharmacology and Experimental Therapeutics · 1991 · 71 citations
Medicine, Neuroscience, Pharmacology +16
Jonas Boström, Kristina Berggren, Thomas Elebring et al. · Bioorganic & Medicinal Chemistry · 2007 · 66 citations · Full text
1–5 of 18